Insider · CIK 0001492256
Robert J. Spiegel
director
Files at GERN (GERON CORP), RNXT (RenovoRx, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | RNXT RenovoRx, Inc. | AGrant or award Stock Options (right to buy)derivative | +55,924 | $0.00 | $0 | 55,924 | 10 d ago |
| Sep 30, 2026 | GERN GERON CORP | AGrant or award Common Stock | +6,351 | $1.23 | $7,812 | 212,161 | 11 d ago |
| Oct 1, 2025 | RNXT RenovoRx, Inc. | AGrant or award Stock Options (right to buy)derivative | +47,640 | $0.00 | $0 | 47,640 | Oct 2, 2025 |
| Sep 30, 2025 | GERN GERON CORP | AGrant or award Common Stock | +5,702 | $1.37 | $7,812 | 188,546 | Oct 1, 2025 |
| Jun 30, 2025 | GERN GERON CORP | AGrant or award Common Stock | +5,540 | $1.41 | $7,811 | 182,844 | Jul 1, 2025 |
| May 21, 2025 | GERN GERON CORP | AGrant or award Stock Option (right to buy)derivative | +180,000 | $0.00 | $0 | 180,000 | May 22, 2025 |
| Mar 31, 2025 | GERN GERON CORP | AGrant or award Common Stock | +4,913 | $1.59 | $7,812 | 177,304 | Apr 2, 2025 |
| Dec 31, 2024 | GERN GERON CORP | AGrant or award Common Stock | +2,206 | $3.54 | $7,809 | 172,391 | Apr 2, 2025 |
| Sep 30, 2024 | GERN GERON CORP | AGrant or award Common Stock | +1,767 | $4.54 | $8,022 | 170,185 | Apr 2, 2025 |
| Mar 29, 2024 | GERN GERON CORP | AGrant or award Common Stock | +2,462 | $3.30 | $8,125 | 166,502 | Apr 2, 2025 |
| Jun 28, 2024 | GERN GERON CORP | AGrant or award Common Stock | +1,916 | $4.24 | $8,124 | 168,418 | Apr 2, 2025 |
| Dec 31, 2024 | GERN GERON CORP | AGrant or award Common Stock | -2,206 | $0.00 | $0 | 172,391 | Jan 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.